Stomach neoplasms
Clinical trials for Stomach neoplasms explained in plain language.
Never miss a new study
Get alerted when new Stomach neoplasms trials appear
Sign up with your email to follow new studies for Stomach neoplasms, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy boosts chemo before stomach cancer surgery in new trial
Disease control OngoingThis phase 2 trial tests whether adding the immunotherapy drug serplulimab to standard chemotherapy before surgery helps patients with advanced stomach or gastroesophageal junction cancer. About 116 participants will receive either the combo or chemo alone for three cycles before…
Matched conditions: STOMACH NEOPLASMS
Phase 2 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Experimental drug duo targets Hard-to-Treat HER2 cancers
Disease control OngoingThis study tests two drugs together—disitamab vedotin and tucatinib—in people with advanced breast or stomach cancers that have a protein called HER2. The goal is to see if the combination is safe and shrinks tumors. About 172 participants will take part.
Matched conditions: STOMACH NEOPLASMS
Phase 2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a Two-Drug combo beat single painkiller after stomach surgery?
Symptom relief OngoingThis trial tests whether a combination of acetaminophen and ibuprofen (Maxigesic) given through an IV can control pain better than acetaminophen alone after laparoscopic or robotic stomach cancer surgery. About 90 adults undergoing this surgery will be randomly assigned to one of…
Matched conditions: STOMACH NEOPLASMS
Phase 2 • Sponsor: Seoul National University Bundang Hospital • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC